Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
7.26 USD | -5.59% | +5.22% | -40.69% |
05-14 | Pulse Biosciences Appoints Burke Barrett as President, CEO | MT |
05-09 | Pulse Biosciences, Inc. Announces First U.S. Procedure with the CellFX nsPFA Percutaneous Electrode System | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration1st Jan change | Capi. | |
---|---|---|
-40.69% | 401M | |
+12.85% | 229B | |
+13.88% | 195B | |
+18.39% | 142B | |
+28.78% | 109B | |
+1.67% | 64.85B | |
+18.24% | 54.33B | |
+7.04% | 52.09B | |
+10.83% | 45.15B | |
+5.94% | 37.39B |
- Stock Market
- Equities
- PLSE Stock
- News Pulse Biosciences, Inc.
- HC Wainwright Adjusts Price Target on Pulse Biosciences to $43 from $46, Keeps Buy Rating